Effectiveness of COVID-19 Vaccines against SARS-CoV-2 Infection among Persons Attending the RT-PCR center at a Medical College Hospital in Telangana: A Case- Control Study

BACKGROUND: In January 2021, India’s drug regulator issued restricted emergency approval for COVISHIELD and COVAXIN, which were manufactured in India. In mid-January 2021, in India, there were 10.5 million confirmed cases and 0.15 million deaths. The objectives were to evaluate vaccine effectiveness...

Descripción completa

Detalles Bibliográficos
Autores principales: Veerapu, Nagapraveen, Inamdar, Dhanashree P, Kumar, Baer P Ravi, Anuradha, Basavaraju, Guddanti, Pavitra, Issapuri, Sree D, Ganta, Nikhita S, Gopi, Arun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891038/
https://www.ncbi.nlm.nih.gov/pubmed/36742954
http://dx.doi.org/10.4103/ijcm.ijcm_273_22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891038/
https://www.ncbi.nlm.nih.gov/pubmed/36742954
http://dx.doi.org/10.4103/ijcm.ijcm_273_22

Ejemplares similares